Ford / Heresi / Risbano Pulmonary Hypertension

Controversial and Emerging Topics
1. Auflage 2020
ISBN: 978-3-030-52787-7
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 206 Seiten, eBook

Reihe: Respiratory Medicine

This book is a clinical guide to controversial and emerging topics in pulmonary hypertension. There are multiple challenges and unanswered questions encountered by clinicians that evaluate, diagnose and treat patients with suspected or confirmed pulmonary vascular disease. This book provides a deep dive into the diagnosis and therapeutics of pulmonary hypertension supported by the literature and balanced with personal clinical experience. Expert authors have chosen these specific topics to address issues where uncertainty and/or controversy exists as well as highlight areas that are just being incorporated into clinical practice. These topics include: exercise pulmonary hypertension, sickle cell disease and pulmonary hypertension, and sarcoid pulmonary hypertension, among many others. Chapters address the diagnostic and treatment dilemmas posed by these various clinical entities through literature review, sharing of expert opinion, and review of recent guidelines and their applicability to the multiple different nuanced presentations of pulmonary hypertension. This is an ideal guide for pulmonologists, cardiologists, and other specialty practitioners caring for patients with pulmonary hypertension.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Ford, H. James

Heresi, Gustavo A.

Risbano, Michael G.

Inhaltsverzeichnis

Exercise pulmonary hypertension.- Advanced Right Ventricular Assessment: Pulmonary Artery Compliance and RV:PA Coupling .- Beyond scleroderma: pulmonary arterial hypertension in patients with other connective tissue diseases.- Isolated Post-capillary and Combined Pre and Post-capillary Pulmonary Hypertension.- Current Approach to Chronic Thromboembolic Disease without Pulmonary Hypertension .- Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.- Controversies in the Management of Pulmonary Hypertension in the Setting of Lung Disease.- Pulmonary Hypertension in Sickle Cell Disease: Current Controversies and Clinical Practices.- Sarcoidosis-Associated Pulmonary Hypertension.- Parenteral Prostacyclin Use in Pulmonary Arterial Hypertension.- Pulmonary Hypertension in Chronic Kidney Disease and End Stage Renal Disease.-  Gender and Race Disparities in Pulmonary Hypertension Diagnosis and Treatment  .

Über Autor(innen)

H. James Ford, MD is Associate Professor of Medicine at the University of North Carolina at Chapel Hill. There he is Director of the Pulmonary Hypertension Program and Co-Medical Director of the UNC Pulmonary Specialty Clinic.

Gustavo A. Heresi, MD, MS is Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, as well as the Director of the Pulmonary Vascular and CTEPH Program  at the Cleveland Clinic in Ohio.

Michael G. Risbano, MD, MA is Assistant Professor of Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Pittsburgh Medical Center. There he is Director of the Invasive Cardiopulmonary Exercise Program and Head of Clinical Operations for Pulmonary Hypertension.